Remove 2026 Remove Drug Development Remove Organic Chemistry Remove Regulations
article thumbnail

Antibody Drug Conjugates: windows of opportunity

Drug Target Review

The global ADC market is expected to continue this steep upward trajectory and is anticipated to exceed $16 Billion by 2026. 1 Regulators invest significant consideration balancing quality-of-life measures with overall survival when assessing novel oncology treatments. Antibody drug conjugated with cytotoxic payload.